e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Translational studies in chronic lung diseases: from bedside to bench
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated serum levels of oxidized low-density lipoprotein in COPD patients
Y. Shen, T. Yang, T. Wang, L. Chen, X. Li, F. Wen (Chengdu, China)
Source:
Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Session:
Translational studies in chronic lung diseases: from bedside to bench
Session type:
Poster Discussion
Number:
254
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Y. Shen, T. Yang, T. Wang, L. Chen, X. Li, F. Wen (Chengdu, China). Elevated serum levels of oxidized low-density lipoprotein in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 254
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Decreased levels of high-density lipoprotein cholesterol in patients with sarcoidosis and relationship with disease activity
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004
Higher plasma cholesterol and low density lipoproteins are associated with increased airway resistance in COPD
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015
LATE-BREAKING ABSTRACT: High density lipoprotein cholesterol (HDL) and severe chronic lung disease (CLD) exacerbations in the general population
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015
Low-density lipoprotein cholesterol is associated with inspiratory capacity to total lung capacity ratio in AECOPD patients
Source: Annual Congress 2012 - New issues in pulmonary function
Year: 2012
Serum total cholesterol, HDL-C and LDL-C levels significantly correlate with the radiological extent of disease and the degree of smear positivity in patients with pulmonary tuberculosis
Source: Eur Respir J 2006; 28: Suppl. 50, 860s
Year: 2006
Relation of low serum lipid levels with coronary atherosclerosi in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 662s
Year: 2006
APOM and high-density lipoprotein cholesterol are associated with lung function and per cent emphysema
Source: Eur Respir J 2014; 43: 1003-1017
Year: 2014
HDL serum levels are significantly lower in patients with COPD than in never-smokers
Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer
Year: 2017
Serum leptin, adponectin and its tissue expression in COPD patients with osteopenic syndrome
Source: International Congress 2015 – COPD: notable points
Year: 2015
Serum lipid levels in patients with bronchiectasis
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008
Serum levels of leptin and visfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Different data in COPD
Year: 2015
Role of serum adiponectin in COPD
Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD
Year: 2008
Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009
Plasma surfactant protein D (SP-D) and nutritive status in patients with COPD
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
Increased total serum levels of ghrelin and nesfatin in chronic obstructive pulmonary disease
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Are the thiol/disulfide redox status and HDL cholesterol levels associated with pulmonary embolism?
Source: International Congress 2017 – Pulmonary embolism
Year: 2017
Is serum cholesterol a risk factor for asthma?
Source: Annual Congress 2012 - Asthma: risk factors and effect of anti-IgE
Year: 2012
Determinants of serum leptin and adiponectin levels in patients with COPD
Source: Eur Respir J 2005; 26: Suppl. 49, 59s
Year: 2005
Relations between serum lipid levels and inflammatory markers in obese asthma.
Source: International Congress 2018 – Physiological and biological insights in asthma
Year: 2018
Total cholesterol and low density lipoprotein (LDL) cholesterol in obstructive sleep apnoea (OSA)
Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept